Literature DB >> 19455630

Age-dependent decreases in serum soluble interleukin-1 receptor type I (sIL-1RI) in healthy individuals: a population study of serum sIL-1RI levels in Japanese subjects.

Yoshihiro Okamoto1, Mayuri Tanaka, Nobuhiro Miyahara, Mie Tanabe, Yoshimitsu Gotoh, Takuhito Nagai, Naoya Fujita, Takashi Fukui, Toshiyuki Masuzawa.   

Abstract

The levels of several soluble cytokine receptors in body fluids of healthy individuals change with age. Clinical application of the measurement of the serum soluble interleukin-1 receptor type I (sIL-1RI) level depends critically on the samples used as the controls. At present, there is no information regarding the levels of serum sIL-1RI in healthy subjects. The purpose of this study is to reveal the age-related changes that occur in the serum sIL-1RIlevels of healthy individuals. We determined the serum sIL-1RI levels of healthy Japanese children using ELISA. The serum sIL-1RI level of children (0-14 years) was significantly higher than that of adults (more than 15 years) (P = 0.0138, n = 90). Thus, it is recommended that when the serum sIL-1RI level of patients is evaluated, it should be compared against age-matched controls. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19455630      PMCID: PMC6649078          DOI: 10.1002/jcla.20315

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  18 in total

1.  Age-dependent levels of select immunological mediators in sera of healthy children.

Authors:  U Sack; U Burkhardt; M Borte; H Schädlich; K Berg; F Emmrich
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

2.  A soluble binding protein specific for interleukin 1 beta is produced by activated mononuclear cells.

Authors:  J A Symons; J A Eastgate; G W Duff
Journal:  Cytokine       Date:  1990-05       Impact factor: 3.861

3.  Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor.

Authors:  W C Fanslow; J E Sims; H Sassenfeld; P J Morrissey; S Gillis; S K Dower; M B Widmer
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

4.  The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor.

Authors:  D Burger; R Chicheportiche; J G Giri; J M Dayer
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

5.  Age-dependent decrease in serum soluble interferon-gamma receptor (sIFN-gammaR) in healthy Japanese individuals; population study of serum sIFN-gammaR level in Japanese.

Authors:  Yoshihiro Okamoto; Kyoko Seta; Izumi Nakajo; Yoshimitsu Gotoh; Takuhito Nagai; Naoya Fujita; Takashi Fukui; Toshiyuki Masuzawa
Journal:  J Immunoassay Immunochem       Date:  2008

6.  Variations in serum soluble IL-2 receptor concentration.

Authors:  A C Jones; C R Besley; J A Warner; J O Warner
Journal:  Pediatr Allergy Immunol       Date:  1994-11       Impact factor: 6.377

Review 7.  The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.

Authors:  F Colotta; S K Dower; J E Sims; A Mantovani
Journal:  Immunol Today       Date:  1994-12

Review 8.  Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis.

Authors:  W P Arend; J M Dayer
Journal:  Arthritis Rheum       Date:  1995-02

Review 9.  Biologic basis for interleukin-1 in disease.

Authors:  C A Dinarello
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

10.  Purification and characterization of a novel soluble receptor for interleukin 1.

Authors:  J A Symons; J A Eastgate; G W Duff
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.